Please login to the form below

Not currently logged in
Email:
Password:

Thomas Lonngren

This page shows the latest Thomas Lonngren news and features for those working in and with pharma, biotech and healthcare.

EMA to stop ‘revolving doors’ committee members

EMA to stop ‘revolving doors’ committee members

Thomas Lönngren took up a new post at the European regulatory and market access firm the NDA Group, just weeks after leaving his position.There were also allegations that he had ... Under these new rules, Lönngren would have had to have stepped away

Latest news

  • Data transparency in Europe Data transparency in Europe

    This is a much different attitude to its former executive director Thomas Lonngren, who through his long tenure at the EMA blocked the active disclosure of data, saying it would affect ... In December 2010 Lonngren left the Agency to work for the NDA

  • European Parliament 'not amused' with EMA failures

    Last year the Parliament did not approve the EMA's 2009 budget until late October, largely because of the conduct of its former head Thomas Lonngren. ... Lonngren joined pharmaceutical consultants NDA just weeks after leaving office in December 2010 and

  • Pharma's biggest news stories in 2011

    A new head for the EMA was also appointed following Thomas Lonngren's departure in December, 2010, with former director-general of the Italian Medicines Agency, Guido Rassi, finally taking over ... Lonngren found himself in the news again rather recently

  • Ex-head of EMA "set up consultancy while still in office"

    Ex-head of EMA "set up consultancy while still in office". Thomas Lonngren faces criticism from transparency pressure groups. ... The former head of the European Medicines Agency (EMA), Thomas Lonngren, is facing criticism for setting up a consultancy

  • Andreas Pott appointed deputy director at the European Medicines Agency

    Pott has spent the last 11 months as the European regulator's acting executive director while it conducted a protracted search for a permanent candidate following the departure of Thomas Lonngren

More from news
Approximately 1 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics